Evidence mapPaperPMID 39430169Full record

ArticleKidney international reports2024

Increased Blood-Brain Barrier Permeability and Cognitive Impairment in Patients With ESKD.

Mickaël Bobot, Eric Guedj, Noémie Resseguier, Julien Faraut, Philippe Garrigue, Vincent Nail, Guillaume Hache, Sandra Gonzalez, Nathalie McKay, Romain Vial and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in Kidney international reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04328415 (Evaluation of the Blood-brain Barrier Disruption During Chronic Kidney Disease by 99mTc-DTPA Cerebral Scintigraphy), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04328415 naunknown statusnot on this map

Evaluation of the Blood-brain Barrier Disruption During Chronic Kidney Disease by 99mTc-DTPA Cerebral Scintigraphy (BREIN)

TypeinterventionalSponsorAssistance Publique Hopitaux De MarseilleRan2020 to 2022Enrolled30ConditionsEnd Stage Renal Disease and Cognitive ImpairmentArmsCerebral scintigraphy
3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Cognitive Impairment Predicts Adverse Outcomes in CKD.Kidney international reports · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mickaël BobotCentre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Marseille, France.
Eric GuedjAPHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Aix Marseille Université, Marseille, France.
Noémie ResseguierCEReSS/UR 3279 - Health Services and Quality of Life Research, Aix Marseille University, Marseille, France.
Julien FarautCentre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Marseille, France.
Philippe GarrigueAix Marseille Université, INSERM 1263, INRAE 1260, C2VN, Marseille, France.
Vincent NailAix Marseille Université, INSERM 1263, INRAE 1260, C2VN, Marseille, France.
Guillaume HacheAix Marseille Université, INSERM 1263, INRAE 1260, C2VN, Marseille, France.
Sandra GonzalezCERIMED, Aix-Marseille Université, Marseille, France.
Nathalie McKayAix Marseille Université, INSERM 1263, INRAE 1260, C2VN, Marseille, France.
Romain VialCentre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Marseille, France.
Dammar BouchouarebCentre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Marseille, France.
Guillaume LanoCentre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Marseille, France.
Noémie Jourde-ChicheCentre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Marseille, France.
Ariane Duval-SabatierCentre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Marseille, France.
Fabrice GuilaumeCentre de Recherche en Psychologie et Neuroscience, CNRS, UMR7077, Aix-Marseille Université, Marseille, France.
Benjamin GuilletAix Marseille Université, INSERM 1263, INRAE 1260, C2VN, Marseille, France.
Stéphane BurteyCentre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Marseille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic kidney disease (CKD) is associated with an increased risk of cognitive impairment. This cognitive impairment is associated with an increased permeability of blood-brain barrier (BBB) in rodents with CKD, linked to activation of aryl hydrocarbon receptor (AhR) by indoxyl sulphate (IS). The objective of the BREIN study was to confirm the increased BBB permeability in humans with CKD. Method: The BREIN comparative study (NCT04328415) prospectively included patients with end-stage kidney disease (ESKD) and controls healthy volunteers matched in age, sex, and level of education to a patient. In all participants, BBB permeability was quantified by brain Results: Fifteen patients with ESKD and 14 healthy volunteers were analyzed. Patients with ESKD had higher BBB permeability compared to controls: 0.29 ± 0.07 versus 0.14 ± 0.06 %IA, Conclusion: Patients with ESKD display an increased BBB permeability compared to matched healthy volunteers. Association with uremic toxins and cognitive impairment needs to be assessed in larger cohorts of patients.

Indexed as

blood-brain barrierchronic kidney diseasecognitive impairmentindoxyl sulphatekidney-brain axisuremic toxins

Identifiers

PMID39430169
PMCPMC11489453

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.